JP2018520366A5 - - Google Patents

Download PDF

Info

Publication number
JP2018520366A5
JP2018520366A5 JP2018503149A JP2018503149A JP2018520366A5 JP 2018520366 A5 JP2018520366 A5 JP 2018520366A5 JP 2018503149 A JP2018503149 A JP 2018503149A JP 2018503149 A JP2018503149 A JP 2018503149A JP 2018520366 A5 JP2018520366 A5 JP 2018520366A5
Authority
JP
Japan
Prior art keywords
glypican
antibody
fluid sample
binding
prostate cancer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2018503149A
Other languages
English (en)
Japanese (ja)
Other versions
JP6760666B2 (ja
JP2018520366A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/AU2016/000260 external-priority patent/WO2017011855A1/en
Publication of JP2018520366A publication Critical patent/JP2018520366A/ja
Publication of JP2018520366A5 publication Critical patent/JP2018520366A5/ja
Application granted granted Critical
Publication of JP6760666B2 publication Critical patent/JP6760666B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2018503149A 2015-07-22 2016-07-22 前立腺疾患のためのバイオマーカーの組み合わせ Expired - Fee Related JP6760666B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AU2015902919 2015-07-22
AU2015902919A AU2015902919A0 (en) 2015-07-22 Biomarker combinations for prostate disease
PCT/AU2016/000260 WO2017011855A1 (en) 2015-07-22 2016-07-22 Biomarker combinations for prostate disease

Publications (3)

Publication Number Publication Date
JP2018520366A JP2018520366A (ja) 2018-07-26
JP2018520366A5 true JP2018520366A5 (enExample) 2019-07-25
JP6760666B2 JP6760666B2 (ja) 2020-09-23

Family

ID=57833476

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2018503149A Expired - Fee Related JP6760666B2 (ja) 2015-07-22 2016-07-22 前立腺疾患のためのバイオマーカーの組み合わせ

Country Status (8)

Country Link
US (1) US20180224454A1 (enExample)
EP (1) EP3325972B1 (enExample)
JP (1) JP6760666B2 (enExample)
KR (1) KR20180030549A (enExample)
CN (1) CN107850600A (enExample)
AU (1) AU2016297676B2 (enExample)
CA (1) CA2993102A1 (enExample)
WO (1) WO2017011855A1 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3003032A1 (en) * 2018-04-27 2019-10-27 Nanostics Inc. Methods of diagnosing disease using microflow cytometry
JP2020028278A (ja) * 2018-08-24 2020-02-27 国立大学法人九州大学 被検体に生じるイベントを予測するための判別器の生成方法、及び前記判別器を用いた被検体の層別化方法
CN113439212B (zh) * 2018-10-05 2025-01-07 美侬米克国际有限公司 用于确定侵袭性前列腺癌的生物标志物组合

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070105105A1 (en) * 2003-05-23 2007-05-10 Mount Sinai School Of Medicine Of New York University Surrogate cell gene expression signatures for evaluating the physical state of a subject
US9353415B2 (en) * 2006-12-19 2016-05-31 Thomson Reuters (Scientific) Llc Methods for functional analysis of high-throughput experimental data and gene groups identified therefrom
WO2008092894A1 (en) * 2007-02-02 2008-08-07 Novartis Ag Modulators of sclerostin binding partners for treating bone-related disorders
WO2015106311A1 (en) * 2014-01-17 2015-07-23 Minomic International Ltd. Cell surface prostate cancer antigen for diagnosis

Similar Documents

Publication Publication Date Title
JP2017518366A5 (enExample)
Farzin et al. Recent advances in design of electrochemical affinity biosensors for low level detection of cancer protein biomarkers using nanomaterial-assisted signal enhancement strategies
JP2015533788A5 (enExample)
JP2016536330A5 (enExample)
JP2017524725A5 (enExample)
JP2018535404A5 (enExample)
JP2014524744A5 (enExample)
JP2020522261A5 (enExample)
RU2016116773A (ru) Способ выявления опухоли поджелудочной железы, антитела и набор для выявления опухоли поджелудочной железы
JP2012019790A5 (enExample)
JP2015527365A5 (enExample)
JP2020510409A5 (enExample)
JP2011509079A5 (enExample)
JP2016500659A5 (enExample)
JP2017520763A5 (enExample)
RU2019104870A (ru) Комбинированный тест на наличие колоректального рака
JP2018515071A5 (enExample)
WO2019074333A3 (ko) 티오레독신 1 에피토프 및 이에 특이적으로 결합하는 단일클론항체
WO2014167969A1 (ja) 大腸がんの検出方法
JP2017532577A5 (enExample)
JP2018520366A5 (enExample)
JP2015514707A5 (enExample)
RU2019110953A (ru) Моноклональное антитело, специфически связывающееся с тиоредоксином-1, и его применение
JP2012531612A5 (enExample)
JP2010526995A5 (enExample)